First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomes
Titel:
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomes
Auteur:
Reck, Martin Ciuleanu, Tudor-Eliade Cobo, Manuel Schenker, Michael Zurawski, Bogdan Menezes, Juliana Richardet, Eduardo Bennouna, Jaafar Felip, Enriqueta Juan-Vidal, Oscar Alexandru, Aurelia Cheng, Ying Sakai, Hiroshi Paz-Ares, Luis Lu, Shun John, Thomas Sun, Xiaowu Moisei, Aniela Taylor, Fiona Lawrance, Rachael Zhang, Xiaoqing Sylvester, Judi Yuan, Yong Blum, Steven I. Penrod, John R. Carbone, David P.